Weekly Market Recap (November 17–21, 2025)

Stocks fell again as a sharp Tech drawdown overshadowed defensive strength. An Nvidia-fueled morning surge reversed into week-long selling; healthcare held up while cyclicals lagged.

Index Performance (Weekly)

Index Weekly Change
S&P 500−1.04%
Nasdaq−1.92%
Dow Jones−0.74%

Sector Snapshot (1-Week)

Communication Services
+1.89%
Healthcare
+1.48%
Consumer Defensive
+0.77%
Real Estate
−0.11%
Utilities
−1.14%
Financial
−1.59%
Industrials
−1.71%
Basic Materials
−1.85%
Energy
−2.66%
Consumer Cyclical
−3.03%
Technology
−4.70%

AI Picks Performance (Week)

Stock Weekly Return Comment
Micron Technology (MU)−14.29%Post-earnings AI-memory shakeout hit semis.
First Solar (FSLR)−1.43%Energy weakness weighed on solar momentum.
Alphabet (GOOGL)+5.14%Communication Services outperformed on flight to quality.

The Score — Stocks That Defined the Week

  • Nvidia (NVDA): Record $57B revenue and raised outlook couldn’t stop an AI-bubble scare; shares −3.2% Thu and −12% MTD.
  • Constellation Energy (CEG): Secured a $1B federal loan to restart Three Mile Island; 20-year power deal with Microsoft; shares +5.3% Wed.
  • Eli Lilly (LLY): Joined the $1T market-cap club on weight-loss drug momentum; shares +1.6% Fri.
  • Gap (GPS): Beat and raised guidance with broad-based demand; shares +8.2% Fri.
  • Lowe’s (LOW) / Home Depot (HD): Lowe’s topped expectations on Pro strength; HD trimmed outlook; LOW +4% Wed.
  • Target (TGT): Cut profit outlook and mapped a $5B 2026 reinvestment plan; shares −2.8% Wed.

Outlook

  • Positioning: Defensive tilt persists as investors fade crowded AI trades.
  • Macro: Rates and holiday-season spending are the next catalysts for cyclicals vs. staples.
  • AI power: Nuclear and 24/7 baseload deals (e.g., CEG–Microsoft) highlight infrastructure beneficiaries beyond semis.

Key Takeaway

A dramatic “up-then-down” Nvidia week underscored AI-trade crowding. Defensives and Healthcare held their ground, while Tech and Cyclicals slid. Power and pharma emerged as the surprise winners of the AI economy narrative.

Sources & Methodology: Market data sourced from TradingView, Finviz, FRED, and SEC EDGAR filings. All analysis and commentary represent the author's independent assessment and is intended for educational purposes only.
Written & reviewed by Luke, Independent Market Analyst
EverHealthAI

Luke — Independent Market Analyst

Luke is an independent market analyst and the founder of EverHealthAI. He covers U.S. equities, geopolitical risk, macroeconomic trends, and AI infrastructure — with a focus on helping long-term investors understand the forces shaping capital markets. All content is written and edited by a human author and is intended for educational purposes only. Learn more →

Scroll to Top